Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study.

Lechowski L, Benoit M, Chassagne P, Vedel I, Tortrat D, Teillet L, Vellas B.

Int J Geriatr Psychiatry. 2009 Apr;24(4):341-6. doi: 10.1002/gps.2125.

PMID:
18814198
2.

Predictive factors of rate of loss of autonomy in Alzheimer's disease patients. A prospective study of the REAL.FR Cohort.

Lechowski L, De Stampa M, Tortrat D, Teillet L, Benoit M, Robert PH, Vellas B; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):100-4.

PMID:
15791353
3.

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

Suh GH, Ju YS, Yeon BK, Shah A.

Int J Geriatr Psychiatry. 2004 Sep;19(9):817-24.

PMID:
15352138
4.

Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.

Palmer K, Lupo F, Perri R, Salamone G, Fadda L, Caltagirone C, Musicco M, Cravello L.

J Alzheimers Dis. 2011;24(1):35-45. doi: 10.3233/JAD-2010-101836.

PMID:
21157019
5.

[Perturbations of activities of daily living in Alzheimer's disease. A study of 172 patients with the using a questionnaire completed by caregivers].

Derouesné C, Thibault S, Lozeron P, Baudouin-Madec V, Piquard A, Lacomblez L.

Rev Neurol (Paris). 2002 Jul;158(6-7):684-700. French.

PMID:
12486898
6.

Role of behavioural disturbance in the loss of autonomy for activities of daily living in Alzheimer patients.

Lechowski L, Dieudonné B, Tortrat D, Teillet L, Robert PH, Benoit M, Forette B, Vellas B; PHRC-REAL.FR (Réseau sur la Maladie d'Alzheimer Français).

Int J Geriatr Psychiatry. 2003 Nov;18(11):977-82.

PMID:
14618547
7.

Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):106-11.

PMID:
15791354
8.

Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease.

Dumont C, Voisin T, Nourhashemi F, Andrieu S, Koning M, Vellas B.

J Nutr Health Aging. 2005;9(3):163-7.

PMID:
15864396
9.

Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).

Guerin O, Soto ME, Brocker P, Robert PH, Benoit M, Vellas B; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):81-4.

PMID:
15791350
10.

Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.

Soto ME, Andrieu S, Cantet C, Reynish E, Ousset PJ, Arbus C, Gillette-Guyonnet S, Nourhashémi F, Vellas B; REAL.FR group.

Dement Geriatr Cogn Disord. 2008;26(2):109-16. doi: 10.1159/000144073. Epub 2008 Jul 11.

PMID:
18617740
11.

The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease.

Mok WY, Chu LW, Chung CP, Chan NY, Hui SL.

Int J Geriatr Psychiatry. 2004 Nov;19(11):1040-6.

PMID:
15481076
12.

Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease.

Spaccavento S, Del Prete M, Craca A, Fiore P.

Arch Gerontol Geriatr. 2009 May-Jun;48(3):356-60. doi: 10.1016/j.archger.2008.03.002. Epub 2008 Apr 29.

PMID:
18448178
13.

Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.

Nourhashemi F, Amouyal-Barkate K, Gillette-Guyonnet S, Cantet C, Vellas B; REAL.FR Group.

J Nutr Health Aging. 2005;9(2):117-20.

PMID:
15791356
14.

Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.

Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B; REAL-FR Group.

Alzheimers Dement. 2008 Jan;4(1):22-9. doi: 10.1016/j.jalz.2007.10.018.

PMID:
18631947
15.

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

Squitti R, Bressi F, Pasqualetti P, Bonomini C, Ghidoni R, Binetti G, Cassetta E, Moffa F, Ventriglia M, Vernieri F, Rossini PM.

Neurology. 2009 Jan 6;72(1):50-5. doi: 10.1212/01.wnl.0000338568.28960.3f.

PMID:
19122030
16.

Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.

Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B.

J Alzheimers Dis. 2012;28(3):647-54. doi: 10.3233/JAD-2011-110713.

PMID:
22045479
17.

Alzheimer's disease progression in the oldest old compared to younger elderly patient: data from the REAL.FR study.

Nourhashémi F, Gillette-Guyonnet S, Rolland Y, Cantet C, Hein C, Vellas B.

Int J Geriatr Psychiatry. 2009 Feb;24(2):149-55. doi: 10.1002/gps.2084.

PMID:
18613005
18.

Rate of progression differs in frontotemporal dementia and Alzheimer disease.

Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D.

Neurology. 2005 Aug 9;65(3):397-403.

PMID:
16087904
19.

Effects of cognitive function on functional decline among community-dwelling non-disabled older Japanese.

Ishizaki T, Yoshida H, Suzuki T, Watanabe S, Niino N, Ihara K, Kim H, Fujiwara Y, Shinkai S, Imanaka Y.

Arch Gerontol Geriatr. 2006 Jan-Feb;42(1):47-58. Epub 2005 Aug 2.

PMID:
16081171
20.

A naturalistic study of galantamine for Alzheimer's disease.

Brodaty H, Woodward M, Boundy K, Barnes N, Allen G; NATURE Investigators.

CNS Drugs. 2006;20(11):935-43.

PMID:
17044730

Supplemental Content

Support Center